Why may reactivators be harmful? Transacted on the example of reactivation of the blockaded acetylcholinesterase
Hopff, W.H.; Waser, P.G.
Pharmaceutica Acta Helvetiae 45(7): 414-423
1970
ISSN/ISBN: 0031-6865 PMID: 5492057 Document Number: 20169
Document emailed within 1 workday
Related Documents
Kuca, K.; Hrabinova, M.; Soukup, O.; Tobin, G.; Karasova, J.; Pohanka, M. 2010: Pralidoxime--the gold standard of acetylcholinesterase reactivators--reactivation in vitro efficacy Bratislavske Lekarske Listy 111(9): 502-504Kuca, K.; Jun, D.; Bajgar, J. 2007: Structural factors influencing potency of currently used acetylcholinesterase reactivators for treatment of cyclosarin intoxications Current Pharmaceutical Design 13(33): 3445-3452
Hroudová, J.; Fisar, Z.ĕk.; Korábečný, J.; Kuča, K. 2011: In vitro effects of acetylcholinesterase inhibitors and reactivators on Complex i of electron transport chain Neuro Endocrinology Letters 32(3): 259-263
Shorokhov, I.A.; Zatsepin, E.P.; Androsov, N.S. 1993: The action of cholinesterase reactivators on the body not related to the recovery of the activity of phosphorylated acetylcholinesterase Eksperimental'naia i Klinicheskaia Farmakologiia 56(4): 62-66
Franchetti, P.; Grifantini, M.; Martelli, S.; Stein, M.L. 1974: Structure-activity relationships in reactivators of acetylcholinesterase inhibited by organophosphoric compounds. 8. Halides of 2- and 4-hydroxy-iminomethyl-1-(omega-(4-imidazolyl)-n-alkyl)pyridinium Il Farmaco; Edizione Scientifica 29(4): 309-316
Patocka, J. 1973: Reactivation of isopropyl-methylphosphonylated bovine erythrocyte acetylcholinesterase by quaternary pyridine-2-aldoximes Sbornik Vedeckych Praci Lekarske Fakulty Karlovy University V Hradci Kralove 16(3): 121-128
Kassa, J. 1998: Comparison of the reactivation effects of the HI-6 oxime and obidoximeon cyclosin-inhibited acetylcholinesterase in the diaphragm and various parts of the brain in rats Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 47(1): 47-50
Bretscher, P.A.; Ogunremi, O.; Menon, J.N. 1997: Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states Behring Institute Mitteilungen 1997(98): 153-159
Harm, W. 1973: T 4 -mediated v-gene reactivation of UV-irradiated phage Ti, and its comparison with host-cell reactivation Mutation Research 17(2): 163-176
Molchanov, V.I.; Popov, V.L. 1985: The forensic physicians of blockaded Leningrad Sudebno-Meditsinskaia Ekspertiza 28(2): 16-18
Khmel'nitskiĭ, O.K. 1985: Pathoanatomical service in World War Ii in blockaded Leningrad Arkhiv Patologii 47(5): 29-36
Ramkhen, V.F. 1971: Experience in the use of 1 of the cholinesterase reactivators--dipyroxime for the treatment of mental disorders Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 71(12): 1872-1877
Kassa, J.; Bajgar, J. 1996: Comparison of the therapeutic effectiveness of selected cholinesterase reactivators with atropine in acute fosdrine poisoning in mice Ceska a Slovenska Farmacie: Casopis Ceske Farmaceuticke Spolecnosti a Slovenske Farmaceuticke Spolecnosti 45(1): 31-34
Kassa, J. 1995: Comparison of the effect of selected cholinesterase reactivators combined with atropine on soman and fosdrin toxicity in mice Sbornik Vedeckych Praci Lekarske Fakulty Karlovy Univerzity V Hradci Kralove. Suppl 38(1): 63-66
Desikan, K.V. 1995: Relapse, reactivation or reinfection? Indian Journal of Leprosy 67(1): 3-11
Khodkova, E.M.; Zavil'gel'skiĭ, G.B. 1978: Phenomenon of w-reactivation in plasmids Molekuliarnaia Biologiia 12(1): 116-122
Karnak, D.; Kayacan, O.; Beder, S. 2002: Reactivation of pulmonary tuberculosis in malignancy Tumori 88(3): 251-254
Domingues, E.; Chaney, K.C.; Scharf, M.J.; Wiss, K. 2012: Imiquimod reactivation of lichen planus Cutis 89(6): 276-277; 283
Kolesnik, I.P.; Gudym, S.I. 1973: Reactivation of pulmonary tuberculosis following resection Problemy Tuberkuleza 51(4): 36-39
Rentier, B. 2003: Mysteries of viral latency and reactivation Bulletin et Memoires de l'Academie Royale de Medecine de Belgique 158(3-4): 169-173; Discussion: 174-175